Cardio Diagnostics Holdings Inc
CDIO0.185USD
-0.027-12.85%
Handelsschluss 05/09, 16:00（ET）Kurse um 15 Minuten verzögert
8.50MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Cardio Diagnostics Holdings Inc Unternehmen
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Unternehmensinformationen
Unternehmens-codeCDIO
Name des UnternehmensCardio Diagnostics Holdings Inc
IPO-datumNov 23, 2021
Gegründet am2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Anzahl der mitarbeiter13
WertpapierartOrdinary Share
GeschäftsjahresendeNov 23
Addresse311 W. Superior Street
StadtCHICAGO
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl60645
Telefon18552269991
Website
Unternehmens-codeCDIO
IPO-datumNov 23, 2021
Gegründet am2021
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
128.34K
-34.95%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.05K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
97.40K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
71.60K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
128.34K
-34.95%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.05K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
97.40K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
71.60K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionäre
Update-Zeit: Fri, May 9
Update-Zeit: Fri, May 9
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Dogan (Meeshanthini)
3.17%
Bd Holding, Inc
3.04%
BlackRock Institutional Trust Company, N.A.
2.05%
Geode Capital Management, L.L.C.
0.70%
Millennium Management LLC
0.49%
Other
90.55%
Aktionärsstatistik
Aktionäre
Anteil
Dogan (Meeshanthini)
3.17%
Bd Holding, Inc
3.04%
BlackRock Institutional Trust Company, N.A.
2.05%
Geode Capital Management, L.L.C.
0.70%
Millennium Management LLC
0.49%
Other
90.55%
Art
Aktionäre
Anteil
Individual Investor
4.22%
Corporation
3.04%
Investment Advisor
2.69%
Investment Advisor/Hedge Fund
1.36%
Hedge Fund
0.62%
Research Firm
0.22%
Venture Capital
0.11%
Other
87.74%
Institutionelle Beteiligung
Update-Zeit: Mon, Mar 3
Update-Zeit: Mon, Mar 3
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
43
6.55M
12.55%
+595.10K
2024Q4
51
6.58M
12.62%
+556.91K
2024Q3
70
5.72M
21.51%
-4.06M
2024Q2
76
5.70M
26.20%
-6.56M
2024Q1
73
5.54M
28.62%
-6.62M
2023Q4
73
5.55M
28.89%
-5.24M
2023Q3
68
4.28M
41.11%
-6.26M
2023Q2
64
4.02M
40.37%
-6.37M
2023Q1
59
3.90M
40.53%
-6.83M
2022Q4
55
3.79M
39.83%
-7.64M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Dogan (Meeshanthini)
1.66M
3.17%
--
--
Mar 20, 2025
Bd Holding, Inc
1.59M
3.04%
--
--
Mar 20, 2025
BlackRock Institutional Trust Company, N.A.
1.07M
2.05%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
364.39K
0.7%
+179.98K
+97.60%
Dec 31, 2024
Millennium Management LLC
256.94K
0.49%
+256.94K
--
Dec 31, 2024
The Vanguard Group, Inc.
232.14K
0.45%
--
--
Dec 31, 2024
HRT Financial LP
155.39K
0.3%
+144.38K
+1.31K%
Dec 31, 2024
Dogan (Timur)
128.34K
0.25%
-68.97K
-34.95%
Mar 20, 2025
Hosseinion (Warren)
116.05K
0.22%
--
--
Mar 20, 2025
Jane Street Capital, L.L.C.
112.56K
0.22%
+112.56K
--
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten